News from delmar pharmaceuticals A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 04, 2014, 08:00 ET

DelMar Pharmaceuticals to Present at the SeeThruEquity Fall Microcap Investor Conference

 DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), a clinical-stage oncology company, will be featured as a presenting company at the SeeThruEquity...

Sep 03, 2014, 08:00 ET

DelMar Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent for VAL-083

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the United States Patent and Trademark Office (USPTO) has issued a...

Aug 29, 2014, 08:00 ET

DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") today announced the filing of June 30, 2014 fiscal year-end financial...

Aug 27, 2014, 14:57 ET

DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference

 DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), developer of advanced cancer therapeutics, will be featured as a presenting company at the 16th...

Aug 19, 2014, 08:00 ET

DelMar Pharmaceuticals Provides Update on Glioblastoma Clinical Trial and Results of Warrant Tender Offer

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company") announced today a protocol amendment to allow for expanded dosing in its...

Jul 24, 2014, 16:07 ET

DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company") announced today that the company's board of directors approved a change of the...

Jul 09, 2014, 08:00 ET

DelMar Pharmaceuticals Receives Funding from the Canadian Federal Government

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") announced today that the company has been awarded a non-refundable financial...

Jun 09, 2014, 07:30 ET

DelMar Pharmaceuticals, Inc. Presentation Now Available for On-Demand viewing at RetailInvestorConferences.com

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma"), a clinical-stage company advancing breakthrough cancer...

Jun 02, 2014, 16:44 ET

DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com June 5th

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma"), a clinical-stage company advancing breakthrough cancer therapeutics...

May 31, 2014, 07:30 ET

DelMar Pharmaceuticals Presents Promising VAL-083 Interim Data from GBM Clinical Trial at ASCO

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") announced the presentation of interim clinical data from the company's ongoing clinical...

May 22, 2014, 08:00 ET

DelMar Pharmaceuticals to Present at the Third Annual Marcum LLP MicroCap Conference

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma"), a clinical-stage company advancing breakthrough cancer...

May 20, 2014, 18:04 ET

DelMar Pharmaceuticals Gives Quarterly Shareholder Update

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") provided a quarterly update and a summary of progress toward the...

May 16, 2014, 08:00 ET

DelMar Pharmaceuticals Updates VAL-083 Glioblastoma Clinical Trial Progress

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") is pleased to provide an update on the company's ongoing Phase I/II clinical trial for...

May 14, 2014, 17:51 ET

DelMar Pharmaceuticals to Present Interim Clinical Data for Ongoing VAL-083 Glioblastoma Multiforme Trial at ASCO

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the Company will present an abstract entitled, "Phase I/II study of...

May 01, 2014, 08:00 ET
May is Brain Tumor Awareness Month. Share your story. Learn more. #BTAM (PRNewsFoto/DelMar Pharmaceuticals Inc.)

Why is glioblastoma so deadly? DelMar discusses the need for new cancer research and treatments for Brain Tumor Awareness Month

Jeffrey Bacha, president and CEO of DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma" or "DelMar") discusses new clinical research and...

Apr 09, 2014, 11:00 ET

DelMar Pharmaceuticals VAL-083 Clinical Trial in GBM Demonstrates Continued and Promising Progress at AACR

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced an update on its ongoing Phase I/II clinical trial with VAL-083 in the...

Apr 07, 2014, 10:30 ET

DelMar Pharmaceuticals Presents Promising Pre-clinical Data with VAL-083 in Lung Cancer

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the presentation of new data in a poster entitled, "In vivo efficacy of...

Apr 02, 2014, 13:20 ET

DelMar Pharmaceuticals to Present Two Abstracts at American Association of Cancer Research (AACR) Annual Meeting

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the Company would present two abstracts at the 105th Annual...

Mar 20, 2014, 08:00 ET

DelMar Pharmaceuticals Gives Quarterly Shareholder Update and Announces Investor Conference Call

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") provided an update as of the quarter ended December 31, 2013 and a...

Mar 04, 2014, 08:00 ET

DelMar Pharmaceuticals to Present at the 26th Annual ROTH Capital Conference

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") a pharmaceutical company developing its VAL-083 chemotherapy as a...